Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysis-Reference-Cited by-同舟云学术

Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysis

Published:2022-04 Issue: Volume:77 Page:102093
ISSN:1877-7821
Container-title:Cancer Epidemiology
language:en
Short-container-title:Cancer Epidemiology

Author:

Pathirana Thanya,Sequeira Rehan,Del Mar Chris,Dickinson James A.,Armstrong Bruce K.,Bell Katy J.L.,Glasziou Paul

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Epidemiology

Reference48 articles.

1. Australian Cancer Incidence and Mortality (ACIM) books: Prostate cancer,2015

2. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men;Catalona;J. Urol.,1994

3. Prostate-specific antigen testing in Australia and association with prostate cancer incidence in New South Wales;Smith;Med. J. Aust.,1998

4. Overdiagnosis in Cancer;Welch;JNCI J. Nat. Cancer Inst.,2010

5. Prostate Cancer Foundation of Australia and Cancer Council Australia. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer. Sydney: Cancer Council Australia.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer;Cancer Cell International;2023-10-19

2. Analysis of Genetic Biomarkers, Polymorphisms in ADME-Related Genes and their Impact on Pharmacotherapy for Prostate Cancer;2023-08-17

3. Clinical efficacy of prostate PI-RADS V2.1 score combined with serum PSA-related indicators in the detection of gray zone prostate cancer;International Urology and Nephrology;2023-07-31

4. Fictitious cases as a methodology to discuss sensitive health topics in focus groups;International Journal of Qualitative Studies on Health and Well-being;2023-07-18

5. Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit;BMJ;2023-05-17